Table 1.
Clinicopathological characteristics of the patients.
| Characteristic | N (%) Median (IQR) |
|---|---|
| Age | 62 (50–80) |
| <70 years | 13 (60%) |
| >70 years | 9 (40%) |
| ECOG | |
| 0 | 18 (82%) |
| 1 | 4 (18%) |
| Primary histology | |
| Ovarian Adenocarcinoma |
5 (21%) 5 |
| Cervical Adenocarcinoma Squamocellular |
3 (14%) 2 1 |
| Endometrial carcinoma Adenocarcinoma |
14 (65%) 14 |
| Lymph nodes metastases location | |
| Regional LN | 9 (31%) |
| Extraregional LN | 20 (69%) |
| Metastatic state | |
| Oligometastatic | 8 (27%) |
| Olgorecurrent | 14 (48%) |
| Oligoprogression | 6 (21%) |
| Oligopersistent | 1 (4%) |
| Timing of metastasis | |
| Synchronous | 3 (10%) |
| Metachronous | 26 (90%) |
| Chemotherapy | |
| Neoadjuvant | 19 (86%) |
| Concurrent | 2 (9%) |
| Oligoprogression | 5 (23%) |
ECOG: Eastern Cooperative Oncology Group status; LN: lymph nodes.